The 52-Week-Low List: 5 Names On Wednesday
A quiet day for new market lows holds a few names with surprisingly loud stories.
Only 5 stocks from the Russell 3000 reached a 52-week low on Wednesday, a small list for a market where the S&P 500 has returned +2.8% over the last month. The largest company on the list is JBT Marel (JBTM), with a market value of about $6.0 billion.
The central question today is what to make of a list where one name, Alignment Healthcare (ALHC), accounts for the most severe recent weakness, having declined 40.6% over the last month. The full data on all 5 names follows below.
The Complete 52-Week-Low List
The table below lists every stock at its 52-week low, largest first, with one-day, one-week, one-month, and one-year returns:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| JBTM | $6.0 Bil | -0.2% | -2.9% | -13.1% | -17.1% |
| ESAB | $4.8 Bil | -0.1% | -8.3% | -8.3% | -28.2% |
| ALHC | $2.6 Bil | -3.4% | -5.5% | -40.6% | -16.4% |
| CPRI | $1.7 Bil | -0.1% | -7.4% | -9.6% | -29.8% |
| BALY | $0.5 Bil | -0.8% | -35.5% | -38.6% | -8.1% |
When does a steep decline meet strong growth?
Alignment Healthcare (ALHC) stands out for its sharp 40.6% slide over the last month, the steepest on the list. Yet this is a business whose revenue grew 37.2% over the last twelve months. The stock now trades at 65.1 times trailing earnings. While other names on the list also show expanding top lines, like JBT Marel (JBTM) with revenue growth of 44.9%, none pair that growth with such a recent, severe price drop.
A low price is a starting point, not a conclusion.
A 52-week-low list is not an automatic buy signal. It is a list of businesses whose market prices reflect maximum pessimism over the past year. The disciplined work is to determine if that pessimism is warranted by a damaged business or if it marks down a solid one. The price is the beginning of the research, not the end of it.
If any of these names tempt you, resist buying a price alone. Our Buy the Dip screen asks the follow-up question that matters: which marked-down stocks still have the growth and cash generation to recover.
Weakness Is Information. It Is Not An Instruction
A 52-week low tells you what the market thinks today. It does not tell you what to do, and acting on price alone is how value traps get bought. The missing ingredient is always the same: is the business still sound?
Asking that question across thousands of stocks, every day, is exactly how the Trefis High Quality (HQ) Portfolio is built: roughly 30 names that pass the quality screens, held with rules instead of nerve. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Let the low list sharpen your watchlist, and let the portfolio carry the risk.